An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial
Condition: COVID-19 Interventions: Drug: Hydroxychloroquine; Drug: Lopinavir / Ritonavir; Drug: Interferon Beta-1A; Drug: Interferon Beta-1B Sponsor: Shahid Beheshti University of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 13, 2020 Category: Research Source Type: clinical trials
An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial
Condition: COVID-19 Interventions: Drug: Hydroxychloroquine; Drug: Lopinavir / Ritonavir; Drug: Interferon Beta-1A; Drug: Interferon Beta-1B Sponsor: Shahid Beheshti University of Medical Sciences Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 13, 2020 Category: Research Source Type: clinical trials
An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial
Condition: COVID-19 Interventions: Drug: Hydroxychloroquine; Drug: Lopinavir / Ritonavir; Drug: Interferon Beta-1A; Drug: Interferon Beta-1B Sponsor: Shahid Beheshti University of Medical Sciences Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 13, 2020 Category: Research Source Type: clinical trials